Literature DB >> 12874323

Role for interleukin-1 beta in Trypanosoma cruzi-induced cardiomyocyte hypertrophy.

Christine A Petersen1, Barbara A Burleigh.   

Abstract

Chagas' disease, the leading cause of heart failure in Latin America, results from infection with the intracellular protozoan parasite Trypanosoma cruzi. Host cell responses elicited in the myocardium early in the infective process are thought to be critical for establishment of infection by this pathogen; however, these changes have not been well characterized. We report here that primary cardiomyocytes undergo hypertrophy as an early response to T. cruzi infection. The T. cruzi-elicited hypertrophic response is characterized by increased expression of genes encoding the contractile proteins MyHC beta and MyHC alpha, followed by an approximately twofold increase in cell size. Hypertrophy was observed in both parasite-containing and noninfected cell populations represented in T. cruzi-infected cultures, indicating the involvement of a soluble mediator in this process. Conditioned medium harvested from T. cruzi-infected cultures, which contained significant levels of interleukin-1 beta (IL-1 beta) but not endothelin-1 or tumor necrosis factor alpha, was sufficient to induce hypertrophy in isolated cardiomyocytes. Addition of a high-affinity receptor chimera, IL-1 trap, to cardiomyocyte cultures blocked the overall increase in cell size elicited by T. cruzi. These novel findings indicate that IL-1 beta, which is rapidly induced in response to T. cruzi, promotes cardiomyocyte hypertrophy early in the infective process and may contribute to maintenance of cardiomyocyte function during establishment of T. cruzi infection in the heart.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874323      PMCID: PMC165999          DOI: 10.1128/IAI.71.8.4441-4447.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Many pathways to cardiac hypertrophy.

Authors:  S F Steinberg
Journal:  J Mol Cell Cardiol       Date:  2000-08       Impact factor: 5.000

2.  Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription.

Authors:  Silvia Vaena de Avalos; Ira J Blader; Michael Fisher; John C Boothroyd; Barbara A Burleigh
Journal:  J Biol Chem       Date:  2001-10-19       Impact factor: 5.157

Review 3.  Cell signalling and Trypanosoma cruzi invasion.

Authors:  Barbara A Burleigh; Aaron M Woolsey
Journal:  Cell Microbiol       Date:  2002-11       Impact factor: 3.715

4.  NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.

Authors:  R R Baliga; D R Pimental; Y Y Zhao; W W Simmons; M A Marchionni; D B Sawyer; R A Kelly
Journal:  Am J Physiol       Date:  1999-11

5.  Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity.

Authors:  F S Machado; G A Martins; J C Aliberti; F L Mestriner; F Q Cunha; J S Silva
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

6.  Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection.

Authors:  S B Petkova; H B Tanowitz; H I Magazine; S M Factor; J Chan; R G Pestell; B Bouzahzah; S A Douglas; V Shtutin; S A Morris; E Tsang; L M Weiss; G J Christ; M Wittner; H Huang
Journal:  Cardiovasc Pathol       Date:  2000 Sep-Oct       Impact factor: 2.185

7.  Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi.

Authors:  A Talvani; C S Ribeiro; J C Aliberti; V Michailowsky; P V Santos; S M Murta; A J Romanha; I C Almeida; J Farber; J Lannes-Vieira; J S Silva; R T Gazzinelli
Journal:  Microbes Infect       Date:  2000-07       Impact factor: 2.700

8.  Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes.

Authors:  S Frantz; R A Kelly; T Bourcier
Journal:  J Biol Chem       Date:  2000-11-16       Impact factor: 5.157

Review 9.  The role of endothelin in the pathogenesis of Chagas' disease.

Authors:  S B Petkova; H Huang; S M Factor; R G Pestell; B Bouzahzah; L A Jelicks; L M Weiss; S A Douglas; M Wittner; H B Tanowitz
Journal:  Int J Parasitol       Date:  2001-05-01       Impact factor: 3.981

10.  Role of cardiac myocyte-derived endothelin-1 in chagasic cardiomyopathy: molecular genetic evidence.

Authors:  Huan Huang; Masashi Yanagisawa; Yaz Y Kisanuki; Linda A Jelicks; Madhulika Chandra; Stephen M Factor; Murray Wittner; Louis M Weiss; Richard G Pestell; Vitaliy Shtutin; Jamshid Shirani; Herbert B Tanowitz
Journal:  Clin Sci (Lond)       Date:  2002-08       Impact factor: 6.124

View more
  29 in total

1.  Comparison between the collagen intensity and mast cell density in the lingual muscles and myocardium of autopsied chronic chagasic and nonchagasic patients.

Authors:  José A Roldão; Marcela Beghini; Luciana S Ramalho; Carla Souza Porto; Denise B R Rodrigues; Vicente P A Teixeira; Sanívia A de Lima Pereira
Journal:  Parasitol Res       Date:  2012-03-13       Impact factor: 2.289

2.  sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.

Authors:  Soyeon Lim; Myung Eun Lee; Jisu Jeong; Jiye Lee; Soyoung Cho; Miran Seo; Sungha Park
Journal:  Inflamm Res       Date:  2018-05-23       Impact factor: 4.575

Review 3.  Endothelin-1 and its role in the pathogenesis of infectious diseases.

Authors:  Brandi D Freeman; Fabiana S Machado; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

4.  A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion.

Authors:  Halime Kenar; Gamze T Kose; Mehmet Toner; David L Kaplan; Vasif Hasirci
Journal:  Biomaterials       Date:  2011-05-12       Impact factor: 12.479

5.  Trypanosoma cruzi infection induces a global host cell response in cardiomyocytes.

Authors:  Patricio A Manque; Christian M Probst; Christian Probst; Mirian C S Pereira; Rita C P Rampazzo; Luiz Shozo Ozaki; L Shozo Ozaki; Daniela P Pavoni; Dayse T Silva Neto; M Ruth Carvalho; Ping Xu; Myrna G Serrano; João M P Alves; Maria de Nazareth S L Meirelles; Samuel Goldenberg; Marco A Krieger; Gregory A Buck
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

6.  Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi.

Authors:  Christine A Petersen; Katherine A Krumholz; Barbara A Burleigh
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells.

Authors:  Shankar Mukherjee; Huan Huang; Stefka B Petkova; Chris Albanese; Richard G Pestell; Vicki L Braunstein; George J Christ; Murray Wittner; Michael P Lisanti; Joan W Berman; Louis M Weiss; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.

Authors:  Aparecida D Malvezi; Carolina Panis; Rosiane V da Silva; Rafael Carvalho de Freitas; Maria I Lovo-Martins; Vera L H Tatakihara; Nágela G Zanluqui; Edecio Cunha Neto; Samuel Goldenberg; Juliano Bordignon; Sueli F Yamada-Ogatta; Marli C Martins-Pinge; Rubens Cecchini; Phileno Pinge-Filho
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

9.  IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis.

Authors:  Paulo Marcos da Matta Guedes; Fredy R S Gutierrez; Flavia L Maia; Cristiane M Milanezi; Grace K Silva; Wander R Pavanelli; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2010-02-16

10.  Serum-mediated activation of macrophages reflects TcVac2 vaccine efficacy against Chagas disease.

Authors:  Shivali Gupta; Trevor S Silva; Jessica E Osizugbo; Laura Tucker; Heidi M Spratt; Nisha J Garg
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.